MSD's pulmonary arterial hypertension (PAH) drug Winrevair has been accelerating at a breakneck pace since its launch earlier this year – and data from a new phase 3 study could give it a turbo boost.

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. Suzanne is a content marketer, writer, and ...

Concerned about fluctuating fuel costs? Confused by mpg claims? Our free calculator helps you work out what you're paying and choose the right engine for your next car. Dino BurattiResearcher & writer ...